EUVIMEDAtrasti EUVIMED
EUVIMED · CrossrefJournal

Cancer Research, Statistics, and Treatment

ISSN 2590-3233 · Ovid Technologies (Wolters Kluwer Health)

Latest articles

  1. Pan-cancer analysis of the spectrum of homologous recombination DNA repair (HRR) pathway genes in the Indian population: A retrospective observational study

    Nasreen Parween, Trisha Dutta Gupta, Paridhy Vanniya Subramanyam, Nishtha Ajit Singh Tanwar, Archana S Narayana, Shabnam Hussain, Nusrath Fathima, Saranya Rangan, Ashwini Prakash, Sharanya Jayaraman, Vyomesh Javle, Pooja Gowda, K Anju, Linu Varghese, Peddagangannagari Sreekanthreddy, Raj Nagarkar, G Chithrathara, Vinusarathy, Rohit Raghunath Ranade, Saikrishna Kolluru, Sankar Srinivasan, Sudip Shrestha, Tushar Patil, Vashisht Maniar, Ashish Joshi, Sutapa Biswas, Ganesh Chandra Subuddhi, Ghanashyam Biswas, Raja Thirumalairaj, Amit Joshi, Kshitij D Rishi, Hitesh M Goswami, Vidya H Veldore

    Published: 2023-10DOI: 10.4103/crst.crst_260_23

  2. Prevalence and factors associated with frailty among older Indian adults with cancer: A single-center cross-sectional analytical study from a geriatric oncology clinic in India

    Abhijith R. Rao, Vanita Noronha, Anant Ramaswamy, Anita Kumar, Anupa Pillai, Arshiya Sehgal, Sharath Kumar, Shreya C. Gattani, Renita Castelino, Ratan Dhekale, Sarika G. Mahajan, Anuradha A. Daptardar, Nabila Ansari, Manjusha Vagal, Lekhika Sonkusare, Jayita K. Deodhar, Purabi Mahajan, Shivshankar Timmanpyati, Vikram Gota, Shripad Banavali, Rajendra A. Badwe, Kumar Prabhash

    Published: 2023-07DOI: 10.4103/crst.crst_241_23

Volumes

2026 · 302025 · 592024 · 1292023 · 2212022 · 2682021 · 2542020 · 3452019 · 742018 · 30

Jūsų darbui tinkamos žinios.

Nuo nemokamos pradžios ir asmeninės literatūros paieškos iki viso Research Suite.

Peržiūrėti tarifus →

Ar įtraukti visi leidėjų pilnieji tekstai?

Ne. Bibliografiniai įrašai, santraukos ir pilnieji tekstai yra skirtingas turinys. Ar pilnasis tekstas prieinamas, priklauso nuo šaltinio, Open Access ir jūsų turimų licencijų. EUVIMED planas nepakeičia papildomų leidėjų teisių.